Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure
2004 ◽
Vol 44
(10)
◽
pp. 2019-2026
◽
Dennis M. McNamara
◽
Richard Holubkov
◽
Lisa Postava
◽
Karen Janosko
◽
Guy A. MacGowan
◽
...
2005 ◽
Vol 14
(3)
◽
pp. 36-37
D.M. McNamara
◽
R. Holubkov
◽
L. Postava
1994 ◽
Vol 24
(2)
◽
pp. 194-198
Jutta Bergler-Klein
◽
Heinz Sochor
◽
Hubert Pouleur
◽
Richard Pacher
◽
Gerold Porenta
◽
...
1993 ◽
Vol 4
(12)
◽
pp. 1109-1114
◽
L. Vacek James
◽
R. Handlin Larry
◽
J. Beaufort Constance
◽
A. Koenig Calverna
Barry M. Massie
◽
Thomas Amidon
1994 ◽
Vol 24
(2)
◽
pp. 194-198
◽
Jutta Bergler-Klein
◽
Heinz Sochor
◽
Hubert Pouleur
◽
Richard Pacher
◽
Gerold Porenta
◽
...
2005 ◽
Vol 149
(5)
◽
pp. 938.e1-938.e7
◽
Martine Blanchet
◽
Richard Sheppard
◽
Normand Racine
◽
Anique Ducharme
◽
Daniel Curnier
◽
...
M. Hamada
◽
H. Okayama
◽
Y. Shigematsu
◽
T. Kobayashi
◽
M. Mukai
◽
...
Elizabeth T. Mansi
◽
Eric S. Johnson
◽
Micah L. Thorp
◽
Alan S. Go
◽
Ming‐Sum Lee
◽
...
1990 ◽
Vol 300
(6)
◽
pp. 354-360
◽
David M. Mirvis
◽
Jerald Insel
◽
Michael J. Boland
◽
Michael P. Cinquegrani
◽
Jamal K. Ghali
◽
...
1993 ◽
Vol 71
(3)
◽
pp. A21-A28
◽
AndréA. van Vliet
◽
Ab J.M. Donker
◽
Jos J.P. Nauta
◽
Freek W.A. Verheugt
Close
Export Citation Format
Close
Share Document
Close